3859 results for «2359»
3859 results
Renal interventions for hypertension
22 May 2019 – From EuroPCR 2019
Consult this session to discover renal interventions for hypertension, with compelling cases such as renal artery denervation in presence of renal artery stenosis, intravascular echo-guided percutaneous revascularisation of a renal artery occlusion in pediatric resistant nefrovascular hypertension, and more!
Mechanical circulatory support in cardiogenic shock
23 May 2019 – From EuroPCR 2019
Consult this session to learn all about mechanical circulatory support in cardiogenic shock: how to select the right circulatory support, how to organise the shock team, and more!
No flow!
22 May 2019 – From EuroPCR 2019
Consult this session to learn more about the management of no-reflow (particularly following PCI or coronary stenting), thanks to a selection of compelling cases.
Catheter-based renal denervation – Back in routine clinical practice?
23 May 2019 – From EuroPCR 2019
Consult this session on catheter-based renal denervation to learn about recent studies, the "ideal patients", the pre-procedural planning and procedural aspects of renal denervation, and more!
Bioresorbable scaffold: new data, new hope?
22 May 2019 – From EuroPCR 2019
Consult this session on bioresorbable scaffold (BRS) to learn about new data and clinical outcomes: FAMTOM II trial, BIOSOLVE-IV registry, and more!
Quantitative angiographic assessment of regurgitation in the era of minimalistic TAVI and MitraClip
23 May 2019 – From EuroPCR 2019
Consult this session to learn about the quantitative angiographic technique to assess valve regurgitation, the potential value of this technique to guide the procedure, and the current limitations and pitfalls of this technology.
Transcatheter left atrial decompression for chronic heart failure: evidence, indications and device options
23 May 2019 – From EuroPCR 2019
Consult this session to learn more about the role of left atrial decompression in the multidisciplinary management of chronic heart failure, the device selection, their specifics and how to use them, and more!
Sizes, wires, and other innovations in TAVI technique and technology
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session on innovations in TAVI technique and technology to learn more about new self-expanding TAVR valve sizes and TAVR wires, emerging developments in self-expandable TAVR implant best practices, and discover how to utilize these new technologies and techniques to achieve the best possible outcomes for AS patients.
MitraClip case in point in Japanese
16 Feb 2020 – From PCR Tokyo Valves 2020
Find out more on the MitraClip NT System Japan post market surveillance, the MitraClip best practice and challenging functional MR cases...
Remaining challenges in TAVI: how to achieve the better lifetime outcomes for AS patients
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to gain insight into the remaining challenges in TAVI, such as providing AS patients with the best possible outcomes over their entire lifetime, improving pacemaker implant rates with self-expandable valves, and more!
Challenging cases on mitral interventions, TAVI and LAA closure
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various challenging cases, such as: systolic anterior motion with mitral regurgitation triggered by TAVI, transcatheter mitral valve repair using MitraClip through atrial septal defect, ACS complicating transcaval TAVI, and more!
Abstracts in Japanese
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover a selection of abstracts submitted during PCR Tokyo Valves 2020, such as: impact of beta blockers on patients undergoing TAVR, predictive factors of no symptomatic improvement after TAVI, and more!
Challenging cases
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover challenging TAVI cases and high-risk procedures, regarding pulmonic valve stenosis and PPM, calcific aortic stenosis, degenerative aortic stenosis, and more. Watch it now to discover the chosen treatment!
How to optimise PCI in a patient with multivessel disease? LIVE Case
19 Dec 2019 – From GulfPCR-GIM 2019
Watch this case of an 81-year-old female with no prior history of CAD who presented with unstable angina. The patient had recent acute coronary syndrome and baseline angiography shows multivessel disease.
The objectives of this case are:
- Assess your patient as a whole package!
- Lesion preparation is key for...
TAVI and others
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn more about a study comparing the treatment's results of patients with bicuspid (BAV) and tricuspid aortic valve (TAV), in whom TAVI was performed, in terms of device success, early safety and clinical efficacy.
Complication cases
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to learn through a selection of complications cases how to manage transcatheter aortic valve migration, aorto-right ventricular fistula after TAVI, and sudden haemodynamic collapse during TAVI.
Session for the Co-medicals in Japanese
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session dedicated to the co-medicals, to discover the nurse's perspective on percutaneous LAA closure, a study on the reduction of scattered radiation exposure in TAVI, and more!
Cases in mitral
15 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various challenging mitral cases, such as MitraClip therapy for dynamic mitral regurgitation with repetitive heart failure exacerbation, transseptal mitral valve-in-valve implantation to elucidate a degree of concomitant aortic valve stenosis, and more!
Cases in Japanese - PCI, MR & TAVI
16 Feb 2020 – From PCR Tokyo Valves 2020
Consult this session to discover various challenging cases, such as: PCI for coronary ischemia after EvolutR implantation, degenerative mitral regurgitation with large gap, bailout of ventricular septal defect after TAVI, and more!
Left ventricular and systolic dimension determines anatomic suitability for transcatheter mitral valve implantation
25 Jun 2020 – From PCR e-Course 2020
A common exclusion for transcatheter mitral valve implantation (TMVI) is a small predicted neo-left ventricular outflow tract (LVOT). Simulation of the neoLVOT is time-consuming, requires multi-detector computerised tomography (MDCT), specialised software, and computer models of the prosthesis. Measurements that do not require neoLVOT simulation may provide...
